Recognized in the Healthcare category of the 2025 Top Innovations contest, Haystack MRD® enables minimal residual disease ...

Cancer is a complex disease that evades the immune system through various mechanisms. The rapid proliferation of cells and their ability to resist therapy make cancer extremely aggressive. Solid ...

GRAND RAPIDS, Mich. — BAMF Health, a cancer treatment center in Grand Rapids, has launched a study to better understand a certain type of breast cancer. The non-invasive study seeks to find whether or ...

A study conducted at The Hormel Institute in Austin, Minn., may have identified a new marker for colon cancer, according to an ABC 6 News report. When researchers looked for the marker in patients, ...

Doctors may be able to spare patients unnecessarily aggressive breast cancer treatments by collecting and testing cancer ...

Stomach cancer is challenging to detect early due to vague symptoms, often diagnosed at advanced stages. Diagnosis involves ...

Researchers from A*STAR Institute of Molecular and Cell Biology (A*STAR IMCB), led by an internationally recognised stem cell expert, have identified markers of two critical stem cell populations that ...

Researchers at the University of Texas at El Paso have developed a device they say can detect cancer markers in the blood with greater responsiveness than current diagnostic methods. The University of ...

Breast cancer remains one of the predominant causes of cancer-related morbidity worldwide. In recent years, research has increasingly focused on the role of immune markers in predicting patient ...

Lung adenocarcinoma (LUAD) is the most common form of lung cancer, accounting for nearly half of cases. Many patients are ...

CAR-T cell therapy has revolutionized the treatment of relapsed and refractory B-acute lymphoblastic leukemia (B-ALL), with remission rates reaching as high as 90%. This therapy modifies a patient’s T ...